Vmbook Online ordering

Laboratory Corp Of America Ho

Laboratory Corporation of America Holdings, commonly known as LabCorp, is a publicly traded company that operates in the healthcare industry. The company is based in Burlington, North Carolina, and provides clinical laboratory and end-to-end drug development services through a network of facilities located throughout the United States and internationally.

LabCorp's stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol "LH." As of March 14, 2023, the company has a market capitalization of approximately $24.3 billion.

LabCorp's business is divided into two reportable segments: LabCorp Diagnostics and Covance Drug Development. LabCorp Diagnostics provides clinical laboratory testing services, including routine, specialty, and esoteric testing, as well as clinical trials support. Covance Drug Development provides drug development services, including clinical trial testing and management, central laboratory services, and Phase I-IV clinical trial services.

LabCorp is known for its scale and breadth of testing services, with a menu of more than 5,000 tests and the ability to process over 2.5 million patient specimens per week. The company serves a diverse range of customers, including individual patients, healthcare providers, hospitals and health systems, biopharma companies, government agencies, and academic institutions.

In terms of financial performance, LabCorp has reported solid revenue and earnings growth in recent years, driven by both organic growth and strategic acquisitions. However, the company has also faced challenges, including reimbursement pressure, declining volumes in certain testing areas, and increased competition. As a result, the company has focused on cost-cutting measures and strategic initiatives to drive growth and improve profitability.